Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1

The non-steroidal anti-inflammatory drugs (NSAIDs) celecoxib and sulindac have been reported to suppress lung cancer migration and invasion. The class III deacetylase sirtuin 1 (SIRT1) possesses both pro- and anticarcinogenic properties. However, its role in inhibition of lung cancer cell epithelial...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Cha, Byong-Ki, Kim, Young-Suk, Hwang, Ki-Eun, Cho, Kyung-Hwa, Oh, Seon-Hee, Kim, Byoung-Ryun, Jun, Hong-Young, Yoon, Kwon-Ha, Jeong, Eun-Taik, Kim, Hak-Ryul
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2016
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5302984/
https://ncbi.nlm.nih.gov/pubmed/27528025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11127
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items